Soleno Therapeutics’ ‘life-changing’ drug nears approval decision

This story first appeared in Adam’s Biotech Scorecard, a subscriber-only newsletter. STAT+ subscribers can sign up here to get it delivered to their inbox.

I can’t stop saying “loraz-a-payum” thanks to Parker Posey in “The White Lotus.”

Housekeeping note: I’ll be in New York City next week for STAT’s Breakthrough Summit East event on March 20. Therefore, this newsletter will take a one-week break. See ‘ya back on March 27.

STAT+ Exclusive Story

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and news alerts.

Already have an account? Log in

View All Plans

To read the rest of this story subscribe to STAT+.

Nighttime resistance exercise ‘activity breaks’ may boost sleep duration, study finds

Resistance exercise ‘activity breaks’ at night may improve sleep length, suggest the findings of a small comparative study published in the open access journal BMJ

July 17, 2024

Researchers find a simple, effective way to reduce medical errors

We trust our doctors with our lives, but the sad and scary fact is that doctors can get things wrong. Approximately 100,000 Americans die each

July 25, 2023

Epigenetic drug-sensitive biomarkers for cancer

Researchers perform an epigenome-wide multi-omic high-throughput screen to identify actionable epigenetic drug-sensitive biomarkers.

August 15, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.